Tumor suppressors in Sox2-mediated lung cancers promote distinct cell intrinsic and immunologic remodeling [scRNA-seq]
Single-cell RNA-seq · mouse · 16 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart.
- Organism
- Mus musculus (mouse)
- Samples
- 16 samples: 4 × Tumor, LN2A, vs 4 × Tumor, p53, vs 4 × Tumor, PTEN, vs 4 × Tumor, SH,Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE295824_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1256447 and SRA study SRP581836. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 16 samples.
How we read this: 4 replicated groups read from 16 sample titles; they account for 16 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8958231 Tumor, LN2A, rep 1 Tumor, LN2A,
- GSM8958232 Tumor, LN2A, rep 2 Tumor, LN2A,
- GSM8958233 Tumor, LN2A, rep 3 Tumor, LN2A,
- GSM8958234 Tumor, LN2A, rep 4 Tumor, LN2A,
- GSM8958235 Tumor, p53, rep 1 Tumor, p53,
- GSM8958236 Tumor, p53, rep 2 Tumor, p53,
- GSM8958237 Tumor, p53, rep 3 Tumor, p53,
- GSM8958238 Tumor, p53, rep 4 Tumor, p53,
- GSM8958239 Tumor, PTEN, rep 1 Tumor, PTEN,
- GSM8958240 Tumor, PTEN, rep 2 Tumor, PTEN,
- GSM8958241 Tumor, PTEN, rep 3 Tumor, PTEN,
- GSM8958242 Tumor, PTEN, rep 4 Tumor, PTEN,
- GSM8958243 Tumor, SH, rep 1 Tumor, SH,
- GSM8958244 Tumor, SH, rep 2 Tumor, SH,
- GSM8958245 Tumor, SH, rep 3 Tumor, SH,
- GSM8958246 Tumor, SH, rep 4 Tumor, SH,
- GSE261643 Hippo deficient cardiac fibroblasts promote atrial remodeling 24 samples shares remodeling, promote
- GSE319318 Inactivation of CDKN2A-ARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment [RNA-Seq] 20 samples shares remodeling, promote
- GSE269347 Daunorubicin-induced T cell remodeling facilitates a high antitumor response to PD-1 blockade therapy by promoting the expansion and effector function of CD8+ prolifeating T cells [scRNA-Seq] 16 samples shares remodeling, scrna-seq
- GSE327565 Sustained Yap/Taz activation promotes aberrant alveolar epithelial cell differentiation and drives persistent fibrotic remodeling 14 samples shares remodeling, promote
- GSE329403 HCN4 gain-of-function mutation increases intrinsic heart rate and limits maladaptive remodeling under pressure overload 14 samples shares remodeling, intrinsic
- GSE267192 PPARγ-dependent Remodeling of Translational Machinery in Adipose Progenitors is Impaired in Obesity [scRNA-seq] 12 samples shares remodeling, scrna-seq
- GSE267890 Tracing immunological interaction in trimethylamine N-oxide hydrogel-derived zwitterionic microenvironment during promoted diabetic wound regeneration 12 samples shares immunologic, promote
- GSE278100 Foxa1-Mediated Chromatin Remodeling and Enhancer Reprogramming Promotes Gemcitabine Resistance in Pancreatic Cancer 54 samples shares remodeling, promote
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.